|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.03 USD | -0.76% |
|
-0.17% | -0.26% |
| 06-04 | Iradimed Insider Sold Shares Worth $285,000, According to a Recent SEC Filing | MT |
| 05-28 | Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing | MT |
Company Valuation: IRADIMED CORPORATION
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 570.3 | 355.5 | 598.4 | 697 | 1,238 | 1,240 | - | - |
| Change | - | -37.67% | 68.32% | 16.49% | 77.54% | 0.23% | - | - |
| Enterprise Value (EV) | 570.3 | 355.5 | 598.4 | 697 | 1,238 | 1,240 | 1,240 | 1,240 |
| Change | - | -37.67% | 68.32% | 16.49% | 77.54% | 0.23% | 0% | 0% |
| P/E | 62.4x | 27.7x | 35.2x | 36.7x | 55.6x | 50.8x | 44.8x | 39x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.7x | 1.1x | 3.3x | 3.3x | 5.56x | 3.4x | 2.6x |
| Capitalization / Revenue | 13.6x | 6.67x | 9.13x | 9.52x | 14.8x | 13.6x | 12.3x | 11x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 13.6x | 12.3x | 11x |
| EV / EBITDA | - | - | - | - | - | 39.5x | 36.2x | 31.8x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 41.5x | 37.9x | 33.3x |
| EV / FCF | - | - | - | - | - | 69.7x | 57.7x | 70.1x |
| FCF Yield | - | - | - | - | - | 1.44% | 1.73% | 1.43% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.74 | 1.02 | 1.35 | 1.5 | 1.75 | 1.91 | 2.165 | 2.49 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 41.81 | 53.3 | 65.56 | 73.24 | 83.81 | 91.2 | 100.9 | 112.6 |
| EBITDA 1 | - | - | - | - | - | 31.4 | 34.3 | 39 |
| EBIT 1 | 9.818 | 15.63 | 20.04 | 21.96 | 26.15 | 29.9 | 32.7 | 37.2 |
| Net income 1 | 9.325 | 12.83 | 17.19 | 19.23 | 22.48 | 24.55 | 27.8 | 31.9 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 46.21 | 28.29 | 47.47 | 55.00 | 97.28 | 97.03 | 97.03 | 97.03 |
| Nbr of stocks (in thousands) | 12,342 | 12,566 | 12,606 | 12,673 | 12,721 | 12,783 | - | - |
| Announcement Date | 2/4/22 | 2/2/23 | 2/8/24 | 2/13/25 | 2/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 50.8x | - | - | - | 1.24B | |
| 39.25x | 5.04x | 28.43x | 0.32% | 13.35B | |
| 30.97x | 7.86x | 23.49x | 1.06% | 3.86B | |
| 22.56x | 2.59x | 19.26x | 1.28% | 1.18B | |
| -12.9x | - | - | - | 335M | |
| Average | 26.13x | 5.16x | 23.73x | 0.89% | 3.99B | |
| Weighted average by Cap. | 36.50x | 5.47x | 26.80x | 0.54% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- IRMD Stock
- Valuation IRADIMED CORPORATION
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
